MHRA Modernises Medicine Information Delivery
Summary
MHRA announced its 'Improving Patient Information' project on 18 March 2026, aimed at modernising how medicines product information is delivered to patients. The initiative seeks to make medicine information more accessible, trusted, and future-ready. A linked research report (80 pages, 1.82 MB) titled 'The Role of Patient Information Leaflets in Meeting the Information Needs of Patients' accompanies the project. The project reflects MHRA's commitment to fully inclusive approaches to medicines information for all patients.
“Your health decisions matter. The information you receive about your medicines should be clear, accessible, and support informed conversations between you and your healthcare professional.”
About this source
The Medicines and Healthcare products Regulatory Agency is the UK's medicines and medical devices regulator. MHRA publications include drug safety alerts, device field safety notices, Class 1-4 defect recalls, guidance updates, and the monthly medicines shortage list. Around 55 publications a month. Device field safety notices in particular are useful because MHRA often publishes them hours before other European regulators (ANSM, BfArM) surface the same recall. Watch this if you manufacture or distribute medicines or medical devices in the UK and EU, run a hospital pharmacy, advise on MHRA licensing, or follow post-market surveillance signals across European markets.
What changed
MHRA announced its 'Improving Patient Information' project to modernise how medicines product information is delivered, making it more accessible, trusted, and future-ready. The initiative includes research on patient information leaflets and reflects a commitment to inclusive approaches to medicines information.
Pharmaceutical companies and healthcare providers should monitor for future guidance on changes to medicine information formats and delivery methods. No immediate compliance obligations are created by this announcement, but stakeholders should prepare for eventual updates to patient-facing medicine documentation standards.
Archived snapshot
Mar 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Regulation
Improving Patient Information
MHRA's Improving Patient Information project aims to modernise how medicines product information is delivered, making it more accessible, trusted, and future-ready.
From: Medicines and Healthcare products Regulatory Agency Published 18 March 2026 Get emails about this page
Documents
Improving Patient Information
HTML
Research on the Role of Patient Information Leaflets in Meeting the Information Needs of Patients
PDF, 1.82 MB, 80 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
Your health decisions matter. The information you receive about your medicines should be clear, accessible, and support informed conversations between you and your healthcare professional. The MHRA is committed to leading a fully inclusive approach to improving medicines information for everyone.
Updates to this page
Published 18 March 2026
Sign up for emails or print this page
Get emails about this page Print this page
Mentioned entities
Related changes
Get daily alerts for MHRA Guidance & Safety
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from MHRA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when MHRA Guidance & Safety publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.